These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38084533)

  • 1. Role of orthopedia homebox protein in subclassification of pulmonary carcinoid tumors: Retrospective analysis of 110 cases.
    Çetin M; Fındık G; Demirağ F; Türk İ; Aydoğdu K
    Indian J Pathol Microbiol; 2023; 66(4):786-789. PubMed ID: 38084533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens.
    Viswanathan K; Borczuk AC; Siddiqui MT
    J Am Soc Cytopathol; 2019; 8(1):39-46. PubMed ID: 30929758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation.
    Moonen L; Mangiante L; Leunissen DJG; Lap LMV; Gabriel A; Hillen LM; Roemen GM; Koch A; van Engeland M; Dingemans AC; Foll M; Alcala N; Fernandez-Cuesta L; Derks JL; Speel EM
    Int J Cancer; 2022 Jun; 150(12):1987-1997. PubMed ID: 35076935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors.
    Nonaka D; Papaxoinis G; Mansoor W
    Am J Surg Pathol; 2016 Jun; 40(6):738-44. PubMed ID: 26927888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
    Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
    Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
    Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
    Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions.
    Moonen L; Derks J; Dingemans AM; Speel EJ
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31597385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations.
    Papaxoinis G; Lamarca A; Quinn AM; Mansoor W; Nonaka D
    Endocr Pathol; 2018 Sep; 29(3):259-268. PubMed ID: 29770932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
    Thomas CF; Tazelaar HD; Jett JR
    Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience.
    Schrevens L; Vansteenkiste J; Deneffe G; De Leyn P; Verbeken E; Vandenberghe T; Demedts M
    Lung Cancer; 2004 Jan; 43(1):39-45. PubMed ID: 14698535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.